Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Ophthalmology · Cystoid Macular Edema

What is CME in Retinitis Pigmentosa? Symptoms & Treatment

At a Glance

Cystoid Macular Edema (CME) is a common complication of retinitis pigmentosa that causes fluid buildup and blurry central vision. Unlike standard RP vision loss, CME is highly treatable with medicated eye drops or pills. Early treatment is crucial to prevent permanent damage to your retina.

In this answer

2 sections

01

How CME Differs from RP Progression

02

Treatment Options for CME

Cystoid Macular Edema (CME) is a very common complication of retinitis pigmentosa (RP) where fluid collects in the center of the retina, called the macula [1][2]. These pockets of fluid, or cysts, cause the macula to swell, which leads to blurry or distorted central vision [3]. Unlike the permanent and gradual vision loss typically caused by the progression of RP itself, the blurriness from CME can often be treated and reversed, especially when caught early [4][5].

How CME Differs from RP Progression

RP typically causes a gradual loss of rod cells, leading to night blindness and a shrinking field of peripheral vision. CME, however, directly impacts the macula—the area of the retina responsible for your sharp, detailed central vision [1].

When CME develops, fluid leaks and forms cysts that can physically compress the nerve fibers in your retina [3]. While the exact cause isn’t completely understood, it may involve inflammation, autoimmune responses, or changes in the blood vessels of the eye [6][7]. Because CME affects the center of your vision, it can cause a sudden or noticeable drop in your ability to read, recognize faces, or see fine details.

Importantly, long-term swelling from CME can eventually decrease the density of your light-sensing cells (photoreceptors) [8][9]. This means that while CME is highly treatable, leaving it untreated for a long time can lead to permanent structural damage and make it harder to fully recover your vision [10][3]. To monitor this swelling, your eye doctor will likely use a quick, non-invasive imaging test called an Optical Coherence Tomography (OCT) scan, which measures the thickness of your macula and tracks your progress over time.

Treatment Options for CME

The primary goal of treating CME is to reduce the fluid swelling and improve or stabilize your vision. Treatment often requires trying a medication for several weeks or a few months to see full results. The most common treatments include:

  • Prescription Eye Drops: Topical carbonic anhydrase inhibitors (CAIs), like dorzolamide eye drops, are frequently used as an initial treatment. Many doctors prefer to start with these drops to minimize systemic side effects, even though oral medications may be more powerful [11].
  • Oral Medications: Oral CAIs, such as acetazolamide pills, have the strongest clinical evidence for successfully pulling fluid out of the retina in RP patients [11]. However, because they affect the whole body, they can cause systemic side effects like fatigue, tingling in the hands and feet, or an increased risk of kidney stones.
  • Steroid Implants or Injections: If CAIs do not work, your doctor may recommend a dexamethasone implant. This is a tiny steroid implant placed inside the eye that releases medication over time. While it can provide significant improvements in swelling and visual clarity, it carries risks, such as a high chance of accelerating cataracts or increasing eye pressure (which can lead to glaucoma). The implant procedure may also need to be repeated eventually [12][13].
  • Other Therapies: For stubborn cases that don’t respond to standard treatments, doctors might use other injectable medications, such as anti-VEGF drugs or tocilizumab, or specialized laser therapies [14][15][16].

By reducing the thickness of the macula, these treatments can successfully improve visual clarity [13][5]. Some debate exists about whether aggressive treatment is necessary for every single patient, as self-reported vision doesn’t always perfectly match the amount of swelling seen on an OCT scan [17]. However, addressing the swelling early usually offers the best chance at recovering your central vision before long-term damage occurs [8].

Common questions in this guide

How is cystoid macular edema different from regular retinitis pigmentosa vision loss?
While retinitis pigmentosa typically causes a gradual loss of peripheral vision and night blindness, CME directly affects the center of the retina. This causes a noticeable, and sometimes sudden, drop in your sharp, detailed central vision.
How do doctors diagnose and monitor CME?
Eye doctors use an Optical Coherence Tomography (OCT) scan to diagnose and monitor CME. This is a quick, non-invasive imaging test that measures the thickness of your macula and tracks whether fluid is decreasing over time.
What are the most common treatments for CME in retinitis pigmentosa?
Treatment often starts with prescription eye drops or oral medications called carbonic anhydrase inhibitors to draw fluid out of the retina. If these are not effective, your doctor may recommend a steroid implant or injection directly into the eye.
Can vision loss from cystoid macular edema be reversed?
Yes, the blurriness from CME can often be reversed if it is caught and treated early. However, leaving the swelling untreated for a long time can cause permanent structural damage to your light-sensing cells, making it harder to fully recover your vision.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What does my OCT scan show regarding the severity and thickness of the swelling in my macula?
  2. 2.Should we start with topical drops to minimize side effects, or is the swelling severe enough to warrant starting with oral pills?
  3. 3.What are the specific warning signs or side effects I should watch out for with the medication you're prescribing?
  4. 4.How long should we try this first-line treatment before deciding if we need to consider an implant or injection?
  5. 5.How often will I need follow-up OCT scans to monitor whether the fluid is decreasing?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can You Drive with Retinitis Pigmentosa? Rules & SafetyIs Cataract Surgery Safe for Retinitis Pigmentosa?Can Diet and Lifestyle Slow Retinitis Pigmentosa?Does Vitamin A Help Retinitis Pigmentosa?How to Join a Retinitis Pigmentosa Clinical TrialIs Retinitis Pigmentosa Hereditary? Genetics ExplainedDoes Late-Onset Retinitis Pigmentosa Progress Slower?Does Retinitis Pigmentosa (RP) Cause Hearing Loss?Why Does Retinitis Pigmentosa Spare Central Vision?Can Retinitis Pigmentosa Be Misdiagnosed?What If Your Retinitis Pigmentosa Genetic Test is Negative?Is Stem Cell Therapy Safe for Retinitis Pigmentosa?Why Does Vision Loss Cause Visual Hallucinations?Will I Go Completely Blind From Retinitis Pigmentosa?

References

References (17)
  1. 1

    OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH RETINITIS PIGMENTOSA-ASSOCIATED CYSTOID MACULAR EDEMA.

    Yeo JH, Kim YJ, Yoon YH

    Retina (Philadelphia, Pa.) 2020; (40(12)):2385-2395 doi:10.1097/IAE.0000000000002756.

    PMID: 31923123
  2. 2

    Ocular abnormalities in a large patient cohort with retinitis pigmentosa in Western China.

    Tan L, Long Y, Li Z, et al.

    BMC ophthalmology 2021; (21(1)):43 doi:10.1186/s12886-020-01797-z.

    PMID: 33461530
  3. 3

    Anatomical and functional correlates of cystic macular edema in retinitis pigmentosa.

    Ruff A, Tezel A, Tezel TH

    PloS one 2022; (17(10)):e0276629 doi:10.1371/journal.pone.0276629.

    PMID: 36269735
  4. 4

    A RANDOMIZED PAIRED-EYE TRIAL OF INTRAVITREAL DEXAMETHASONE IMPLANT FOR CYSTOID MACULAR EDEMA IN RETINITIS PIGMENTOSA.

    Park UC, Park JH, Ma DJ, et al.

    Retina (Philadelphia, Pa.) 2020; (40(7)):1359-1366 doi:10.1097/IAE.0000000000002589.

    PMID: 31166248
  5. 5

    Resolution of cystoid macular edema with topical carbonic anhydrase inhibitor in a patient with retinal dystrophy associated with Cohen syndrome.

    Sevik MO, Aykut A, Şahin Ö

    Ophthalmic genetics 2021; (42(5)):619-623 doi:10.1080/13816810.2021.1925928.

    PMID: 33974487
  6. 6

    Inherited retinal disease-associated uveitis.

    Hung JH, Jain T, Khatri A, et al.

    Survey of ophthalmology 2025; (70(5)):951-981 doi:10.1016/j.survophthal.2025.03.011.

    PMID: 40157547
  7. 7

    Choroidal vascular index in cystoid macular edema associated with retinitis pigmentosa.

    Tellioglu A, Aydin R

    Photodiagnosis and photodynamic therapy 2023; (42()):103492 doi:10.1016/j.pdpdt.2023.103492.

    PMID: 36863430
  8. 8

    Evaluation of photoreceptor features in retinitis pigmentosa with cystoid macular edema by using an adaptive optics fundus camera.

    Kitahata S, Gocho K, Motozawa N, et al.

    PloS one 2024; (19(1)):e0296493 doi:10.1371/journal.pone.0296493.

    PMID: 38166083
  9. 9

    Exploring the role of hyperreflective walls as a biomarker for the management of cystoid macular edema.

    Yang ZR, Li C, Xing DJ, et al.

    International journal of ophthalmology 2025; (18(9)):1697-1704 doi:10.18240/ijo.2025.09.11.

    PMID: 40881438
  10. 10

    Tocilizumab for cystoid macular edema secondary to retinitis pigmentosa.

    Abramowicz S, Kamgang Semeu P, Nubourgh I, et al.

    Journal of ophthalmic inflammation and infection 2024; (14(1)):47 doi:10.1186/s12348-024-00430-0.

    PMID: 39349884
  11. 11

    Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review.

    Bakthavatchalam M, Lai FHP, Rong SS, et al.

    Survey of ophthalmology 2018; (63(3)):329-339 doi:10.1016/j.survophthal.2017.09.009.

    PMID: 28987613
  12. 12

    DEXAMETHASONE IMPLANT VERSUS TOPICAL CARBONIC ANHYDRASE INHIBITORS IN PATIENTS WITH BILATERAL RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA: A Prospective, Paired-Eye Pilot Study.

    Colombo L, Montesano G, Di Domenico A, et al.

    Retina (Philadelphia, Pa.) 2024; (44(5)):852-860 doi:10.1097/IAE.0000000000004039.

    PMID: 38166238
  13. 13

    Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa.

    Veritti D, Sarao V, De Nadai K, et al.

    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2020; (36(3)):190-197 doi:10.1089/jop.2018.0153.

    PMID: 31886707
  14. 14

    Comparison of intravitreal anti-VEGF agents and oral carbonic anhydrase inhibitors in the treatment of cystoid macular edema secondary to retinitis pigmentosa.

    Liang J, Wu X, Chen L, et al.

    Frontiers in pharmacology 2024; (15()):1477889 doi:10.3389/fphar.2024.1477889.

    PMID: 39737070
  15. 15

    TOCILIZUMAB RESOLVES REFRACTORY MACULAR EDEMA ASSOCIATED TO RETINITIS PIGMENTOSA.

    Méndez-Martínez S, Pardiñas Barón N, Bartol-Puyal FA, et al.

    Retinal cases & brief reports 2024; (18(3)):387-392 doi:10.1097/ICB.0000000000001389.

    PMID: 36730111
  16. 16

    Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser.

    Arslan U

    Lasers in medical science 2021; (36(2)):317-323 doi:10.1007/s10103-020-03031-0.

    PMID: 32363437
  17. 17

    Self-reported visual function and in-depth swept-source optical coherence tomography features of cystoid macular edema in retinitis pigmentosa.

    Costa C, Nogueira C, Soares M, et al.

    International journal of retina and vitreous 2024; (10(1)):89 doi:10.1186/s40942-024-00608-7.

    PMID: 39578919

This page explains Cystoid Macular Edema (CME) in retinitis pigmentosa for educational purposes only. Always consult your ophthalmologist or retina specialist for diagnosis, OCT scans, and specific treatment decisions.

Get notified when new evidence is published on Retinitis pigmentosa.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.